<PAGE>
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-K/A
[X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
ACT OF 1934
For the fiscal year ended April 30, 2000 or
--------------
[_] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934
For the transition period from _____________ to _____________
Commission file number 0-5286
------
KEWAUNEE SCIENTIFIC CORPORATION
-------------------------------
(Exact name of registrant as specified in its charter)
Delaware 38-0715562
------------------------------- ---------------------------------
(State or other jurisdiction of (IRS Employer Identification No.)
incorporation or organization)
2700 West Front Street
Statesville, North Carolina 28677-2927
------------------------------- ---------------------------------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (704) 873-7202
--------------
Securities registered pursuant to Section 12(b) of the Act: None
----
Securities registered pursuant to Section 12(g) of the Act:
Common Stock $2.50 par value
----------------------------
(Title of Class)
Indicate by check mark whether the Registrant (1) has filed all reports required
to be filed by section 13 or 15(d) of the Securities Exchange Act of 1934 during
the preceding 12 months (or for such shorter period that the Registrant was
required to file such reports), and (2) has been subject to such filing
requirements for the past 90 days. Yes X No
----- -----
Indicate by check mark if disclosure of delinquent filers pursuant to Item 405
of Regulation S-K is not contained herein, and will not be contained, to the
best of Registrant's knowledge, in definitive proxy or information statements
incorporated by reference in Part III of this Form 10-K or any amendment to this
Form 10-K. [X]
The aggregate market value of 1,799,309 shares of voting stock held by non-
affiliates of the Registrant was approximately $23,391,017 based on the last
reported sale price of the Registrant's Common Stock on July 7, 2000. (Only
shares beneficially owned by directors of the Registrant (excluding shares
subject to options) were excluded as shares held by affiliates. By including or
excluding shares owned by anyone, the Registrant does not admit for any other
purpose that any person is or is not an affiliate of the Registrant.)
As of July 7, 2000, the Registrant had outstanding 2,465,871 shares of Common
Stock.
<PAGE>
Kewaunee Scientific Corporation
Form 10-K/A Annual Report
For the Fiscal Year Ended April 30, 2000
This amendment on Form 10-K/A to the Company's Form 10-K for the
fiscal year ended April 30, 2000 solely includes a new Exhibit 13.1 which
corrects, replaces and supersedes page 22 of the Company's Annual Report to
Stockholders which was previously filed as Exhibit 13 to the Company's Form
10-K. The corrected page 22 of the Annual Report to Stockholders merely corrects
the historical high and low prices of the Company's Common Stock for fiscal year
2000.
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities
Exchange Act of 1934, the Registrant has duly caused this report to be signed on
its behalf by the undersigned, thereunto duly authorized.
KEWAUNEE SCIENTIFIC CORPORATION
By: /s/ Eli Manchester, Jr.
------------------------------------
Eli Manchester, Jr.
Chairman and Chief Executive Officer
Date: August 4, 2000
2
<PAGE>
KEWAUNEE SCIENTIFIC CORPORATION
Exhibit Index
-------------
<TABLE>
<CAPTION>
Page Number
(or Reference)
--------------
<S> <C> <C>
13.1 Page 22 of the Annual Report to Stockholders for the
fiscal year ended April 30, 2000
</TABLE>
3
